Page Areas:

Additional Information:

Tiemann-Boege Awarded Pilgerstorferpreis

Hier den Alternativtext zum Bild eingeben!

[2016/07/07] Assoc. Prof. Dr. Irene Tiemann-Boege was awarded the Pilgerstorferpreis from the Medical Society of Upper Austria.

Heißl awarded ÖAW Doc Fellowship

Hier den Alternativtext zum Bild eingeben!

[2016/03/04] Angelika Heißl's 3-year DOC fellowship granted by the Austrian Acadamy of Sciences (ÖAW) started on the 1 January 2016. The title is: "Meiotic recombination as a potential driver of microsatellite evolution". The Awards Ceremony (Stipendienverleihung) took place on 4 March 2016 in Vienna. ...  more of Heißl awarded ÖAW Doc Fellowship (Titel)

Tiemann-Boege: Winner of the OOE Forscherinnen Award 2015, Category “Gesundheit”

Hier den Alternativtext zum Bild eingeben!

Preis vom Land OÖ in der Kategorie für interdisziplinäre Forschung

Hier den Alternativtext zum Bild eingeben!

Assistant Professor Dr. Irene Tiemann-Boege and team won the 2015 Regional Award from the State of Upper Austria for Outstanding Research and Collaborative Effort. They were awarded winner in the category of Arts and Science.

Position Indication:


Mutagenic properties of recombination hotspots↵

FWF Stand-alone Project P23811

Project Start: April 2011

Recombination occurs in small localized regions 0.5-2 kilobases in size known as hotspots. Hotspot activity is highly variable among different individuals. Models about recombination hotspots are incomplete and controversial with several bizarre findings such as the hotspot paradox, rapid hotspot turnover during evolution and what appear to be heritable shifts in how hotspots are recruited for recombination. Not much is known about what drives hotspot activity, but new evidence supports that Prdm9, a zinc finger protein that acts as a histone methyltransferase, is a trans-activating factor regulating mammalian hotspot usage. The Prdm9 gene is highly variable especially in its Zinc fingers contacting the DNA and can accommodate changes in the DNA recognition sequence. This finding is very relevant because it suggest first, that sequence determinants play a pivotal role in meiotic recombination, and second, that there are mechanisms in place to balance variation in these sequence determinants. But why are sequence determinants that drive hotspot usage so variable and what are the main factors influencing this evolution? It has been argued that recombination leads to de novo mutations. Mutations could be an important driver of sequence evolution and influence hotspot activity. The observation that recombination is mutagenic is based on indirect sequence comparisons that have been quite controversial
The aim of this project is to experimentally investigate the mutagenic activity of meiosis in humans. Specifically, the number of new mutations introduced in recombination products will be measured and counted. The study includes the study of mutations in both crossovers and conversion products. These measurements will provide for the first time experimental verification whether recombination is mutagenic in humans. The results will be integrated into models of hotspot turnover and sequence evolution. This proposal addresses a small piece of the complexity of recombination hotspots, but it is crucial for understanding the bigger picture of what factors might influence recombination activity and its evolution.